Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature
- PMID: 15743696
- DOI: 10.1016/j.oraloncology.2004.12.004
Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature
Abstract
Adenoid cystic carcinoma (ACC) is a rare epithelial tumor with a distinct natural history characterized by an indolent but persistent growth, late onset of distant metastases and eventual death of patients. Between 1991 and 2003, 23 patients with ACC were treated in our Department. Surgery with a curative intent followed by radiotherapy (RT) was applied in 22 patients. Complete resection was achieved in 72.73% of patients. Local recurrence occurred in 26% of patients. Positive margins emerged as the only statistically significant parameter (p < 0.0001) influencing the development of local recurrence. Distant metastasis (DM) occurred in 47.8% of patients. In 54.5% of the patients developing DM, this occurred between 5 and 10 years after the initial treatment. DM was influenced by perineural invasion (p = 0.04) and was disassociated from local control of the tumor. The mean overall survival of our patients was 70.58 months and the mean disease free survival 61.85 months. Perineural invasion (p = 0.048) and DM (p = 0.001) had a statistically significant impact on final patients' outcome. The most important factor influencing survival was DM. Its late onset, irrespectively of local control, supports the hypothesis that ACC has a potential to develop DM in the very early phases of tumor growth.
Similar articles
-
Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection.Laryngoscope. 2010 Jan;120(1):65-70. doi: 10.1002/lary.20684. Laryngoscope. 2010. PMID: 19877226
-
Prognostic factors affecting the clinical outcome of adenoid cystic carcinoma of the head and neck.Jpn J Clin Oncol. 2007 Nov;37(11):805-11. doi: 10.1093/jjco/hym119. Jpn J Clin Oncol. 2007. PMID: 18057012
-
Adenoid cystic carcinoma of the head and neck--a 20 years experience.Int J Oral Maxillofac Surg. 2004 Jan;33(1):25-31. doi: 10.1054/ijom.2003.0448. Int J Oral Maxillofac Surg. 2004. PMID: 14690656 Review.
-
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience.Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1365-72. doi: 10.1016/j.ijrobp.2007.08.008. Epub 2007 Oct 29. Int J Radiat Oncol Biol Phys. 2008. PMID: 18029108
-
Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review.Head Neck. 2011 Jun;33(6):905-11. doi: 10.1002/hed.21458. Epub 2010 Jul 22. Head Neck. 2011. PMID: 20652885 Review.
Cited by
-
Salivary gland cancer stem cells.Oral Oncol. 2013 Sep;49(9):845-853. doi: 10.1016/j.oraloncology.2013.05.013. Epub 2013 Jun 28. Oral Oncol. 2013. PMID: 23810400 Free PMC article. Review.
-
Clinicopathological review and survival characteristics of adenoid cystic carcinoma.Indian J Otolaryngol Head Neck Surg. 2015 Mar;67(Suppl 1):62-6. doi: 10.1007/s12070-014-0755-x. Epub 2014 Aug 5. Indian J Otolaryngol Head Neck Surg. 2015. PMID: 25621256 Free PMC article.
-
Skull base invasion of adenoid cystic carcinoma of the lacrimal gland : a case report.J Korean Neurosurg Soc. 2008 Oct;44(4):273-6. doi: 10.3340/jkns.2008.44.4.273. Epub 2008 Oct 30. J Korean Neurosurg Soc. 2008. PMID: 19096692 Free PMC article.
-
Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.Anticancer Res. 2017 Jun;37(6):3045-3052. doi: 10.21873/anticanres.11659. Anticancer Res. 2017. PMID: 28551643 Free PMC article.
-
Nasopharyngeal adenoid cystic carcinoma presenting with exophthalmos: A case report.Radiol Case Rep. 2021 Feb 15;16(4):956-960. doi: 10.1016/j.radcr.2021.02.011. eCollection 2021 Apr. Radiol Case Rep. 2021. PMID: 33664920 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical